Abstract | OBJECTIVE: To determine the response to treatment of pediatric patients diagnosed with autoimmune inner ear disease. PATIENTS: INTERVENTION: Diagnosis through blood testing. Treatment with steroids and/or cytotoxic medication. MAIN OUTCOME MEASURES: Improvement in pure-tone average and speech discrimination scores on audiometric testing. RESULTS: Six of the 7 children (85.7%) improved with treatment, and the remaining patient had no measurable progression of disease. CONCLUSION: Children with autoimmune inner ear disease seem to benefit from treatment with steroids and/or cytotoxic medication. Although such medications must be used with caution in the pediatric population, they should not be withheld simply because of young age.
|
Authors | Natalie C Huang, Robert T Sataloff |
Journal | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
(Otol Neurotol)
Vol. 32
Issue 2
Pg. 213-6
(Feb 2011)
ISSN: 1537-4505 [Electronic] United States |
PMID | 21178803
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- HLA-DR4 Antigen
- Steroids
- Cyclophosphamide
- Prednisone
- Methotrexate
|
Topics |
- Adolescent
- Anti-Inflammatory Agents
(therapeutic use)
- Antimetabolites, Antineoplastic
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Agents, Alkylating
(therapeutic use)
- Auditory Threshold
- Autoimmune Diseases
(immunology)
- Blotting, Western
- Bone Conduction
- Child
- Child, Preschool
- Cyclophosphamide
(therapeutic use)
- Female
- HLA-DR4 Antigen
(immunology)
- Hearing Loss, Sensorineural
(immunology)
- Hematologic Tests
- Humans
- Labyrinth Diseases
(immunology)
- Male
- Methotrexate
(therapeutic use)
- Prednisone
(therapeutic use)
- Retrospective Studies
- Speech Perception
- Steroids
(therapeutic use)
|